Corpus Intelligence IC Memo — HOLZER 2026-04-26 12:37 UTC
IC Memo — HOLZER
Investment Committee Memorandum | OH | 148 beds | Grade C | EBITDA uplift $15.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HOLZER

CCN 360054 | GALLIA, OH | 148 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HOLZER is a 148-bed suburban community hospital in GALLIA, OH with $204.1M in net patient revenue and a 16.9% operating margin. The hospital serves a payer mix of 27.0% Medicare, 3.2% Medicaid, and 69.8% commercial.

Thesis: Turnaround. Our ML models identify $15.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.9% to 24.3% (+736bps).

Net Revenue HCRIS$204.1M
Current EBITDA COMPUTED$34.5M
Operating Margin COMPUTED16.9%
Occupancy HCRIS28.1%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS33.5%
Distress Probability ML53.2%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
89
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 16.9% places it above the state median. Among 89 size-comparable peers (74-296 beds), the median margin is 0.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (74-296), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HOLZER (Target)OH148$204.1M16.9%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
GENESIS HEALTHCARE SYSTEMOH282$527.6M0.6%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
ADENA REGIONAL MEDICAL CENTEROH209$470.7M3.5%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%
SOUTHWEST GENERAL HEALTH CENTEOH191$406.9M2.5%
MEDCENTRAL HEALTH SYSTEMOH240$382.6M0.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.3M+210bp18mo
Cost to Collect4.5%2.5%$4.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$131K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.3M
Cost to Collect
$4.1M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.5M
Clean Claim Rate
$131K
Total EBITDA Uplift$15.0M
Current EBITDA$34.5M
+ RCM Uplift+$15.0M
Pro Forma EBITDA$49.5M
Current Margin16.9%
Pro Forma Margin24.3%
WC Released (1x)$7.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$53.1M$377.9M7.12x48.1%
Base (11x exit)10.0x11.0x$53.1M$433.0M8.15x52.1%
Bull Case9.0x11.0x$47.8M$499.8M10.46x59.9%
Bull (12x exit)9.0x12.0x$47.8M$559.4M11.70x63.5%
Bear Case11.0x10.0x$58.4M$285.6M4.89x37.4%
Bear (11x exit)11.0x11.0x$58.4M$333.1M5.70x41.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 28.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 53.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 74-296 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-9.7% / P50=0.3% / P75=7.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.